India’s Sickle Cell Burden Calls for Specialised, Lifelong Care
From The Indian Practitioner — India’s Sickle Cell Burden Calls for Specialised, Lifelong Care Read the original report from The Indian Practitioner .
Research readouts, treatment and access decisions, and community updates for people living with sickle cell disease and the people who care for them — each one dated, with a link to the original source where there is one.
436 articlesFree, no login required
Looking for earlier coverage? Browse the news archive.
From The Indian Practitioner — India’s Sickle Cell Burden Calls for Specialised, Lifelong Care Read the original report from The Indian Practitioner .
From BusinessLine — Specialised, lifelong care hubs for sickle cell disease Read the original report from BusinessLine .
From TheWire.in — Educating People on Sickle Cell Disease Read the original report from TheWire.in .
From Trinidad Guardian — A new breakthrough in the fight against sickle cell disease Read the original report from Trinidad Guardian .
From Clinical Lab Products — Genetic Testing Reveals Gaps in Sickle Cell and Thalassemia Carrier Documentation Read the original report from Clinical Lab Products .
From Everyday Health — Can These 6 Supplements Help You Manage Sickle Cell Disease? Read the original report from Everyday Health .
From The FAMUAN — Carrying the cause: Tallahassee’s sickle cell warriors Read the original report from The FAMUAN .
From Medical Xpress — Genetic testing may help identify inherited blood disorder carrier status earlier Read the original report from Medical Xpress .
From Jacksonville Free Press — My Son Died of Sickle Cell Disease. The World Still Doesn’t Understand It Read the original report from Jacksonville Free Press .
From Bioengineer.org — MCV Fails to Reliably Separate Sickle Cell and Thalassemia in Western Kenya Study Read the original report from Bioengineer.org .
Mitapivat achieved a 40.6% hemoglobin response rate in the RISE UP Phase 3 trial, with its endpoint strategy potentially influencing future approaches in rare disease drug…
A clinical trial at King Faisal Specialist Hospital and Research Centre aims to advance gene therapy for sickle cell disease, with plans extending to 2026. Read the original…